Table 5 Post-procedural follo-up
|  | EES group | BVS group | χ2 test | p value | Sig. | |
|---|---|---|---|---|---|---|
No. = 40 | No. = 20 | |||||
Mortality | ||||||
 1 month | Negative | 40 (100%) | 20 (100%) | – | – | – |
Positive | 0 (0%) | 0 (0%) | ||||
 6 months | Negative | 40 (100%) | 20 (100%) | – | – | – |
Positive | 0 (0%) | 0 (0%) | ||||
 1 year | Negative | 40 (100%) | 20 (100%) | – | – | – |
Positive | 0 (0%) | 0 (0%) | ||||
Non-fatal MI | ||||||
 1 month | Negative | 40 (100%) | 20 (100%) | – | – | – |
Positive | 0 (0%) | 0 (0%) | ||||
 6 months | Negative | 40 (100%) | 20 (100%) | – | – | – |
Positive | 0 (0%) | 0 (0%) | ||||
 1 year | Negative | 39 (97.5%) | 20 (100%) | 0.508 | 0.476 | NS |
Positive | 1 (2.5%) | 0 (0%) | ||||
UA requiring hospitalization | ||||||
 1 month | Negative | 40 (100%) | 20 (100%) | – | – | – |
Positive | 0 (0%) | 0 (0%) | ||||
 6 months | Negative | 25 (62.5%) | 14 (70%) | 0.330 | 0.566 | NS |
Positive | 15 (37.5%) | 6 (30.0%) | ||||
 1 year | Negative | 39 (97.5%) | 20 (100%) | 0.508 | 0.476 | NS |
Positive | 1 (2.5%) | 0 (0%) | ||||
Multi-slice CT (MSCT) | ||||||
 6 months | Patent | 36 (90%) | 18 (90%) | 0.000 | 1.000 | NS |
Occluded | 4 (10%) | 2 (10%) | ||||
 1 year | Patent | 36 (90%) | 18 (90%) | 0.000 | 1.000 | NS |
Occluded | 4 (10%) | 2 (10%) | ||||